PH30130A - Lacidipine for the treatment of arteriosclerosis - Google Patents

Lacidipine for the treatment of arteriosclerosis

Info

Publication number: PH30130A
Authority: PH; Philippines
Prior art keywords: lacidipine; arteriosclerosis; treatment; pyridinedicarboyxlic; dimethylethoxy
Prior art date: 1991-02-13

Application number

PH43915A

Other languages

English (en)

Inventor

Giovanni Gaviraghi

Original Assignee

Glaxo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-13

Filing date

1992-02-12

Publication date

1997-01-21

1992-02-12 Application filed by Glaxo Spa filed Critical Glaxo Spa

1997-01-21 Publication of PH30130A publication Critical patent/PH30130A/en

Links

206010003210 Arteriosclerosis Diseases 0.000 title abstract 2
208000011775 arteriosclerosis disease Diseases 0.000 title abstract 2
GKQPCPXONLDCMU-CCEZHUSRSA-N lacidipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C GKQPCPXONLDCMU-CCEZHUSRSA-N 0.000 title abstract 2
229960004340 lacidipine Drugs 0.000 title abstract 2
VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PH43915A 1991-02-13 1992-02-12 Lacidipine for the treatment of arteriosclerosis PH30130A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITMI910359A IT1244728B (it)	1991-02-13	1991-02-13	Impiego medicamentoso di derivati diidropiridinici

Publications (1)

Publication Number	Publication Date
PH30130A true PH30130A (en)	1997-01-21

Family

ID=11358541

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH43915A PH30130A (en)	1991-02-13	1992-02-12	Lacidipine for the treatment of arteriosclerosis

Country Status (23)

Country	Link
US (1)	US5455257A (fr)
EP (2)	EP0576433A1 (fr)
JP (1)	JP2996725B2 (fr)
KR (1)	KR100188171B1 (fr)
AT (1)	ATE157004T1 (fr)
AU (1)	AU646929B2 (fr)
CA (1)	CA2103805C (fr)
CZ (1)	CZ281760B6 (fr)
DE (1)	DE69221649T2 (fr)
DK (1)	DK0499920T3 (fr)
ES (1)	ES2106098T3 (fr)
GR (1)	GR3024661T3 (fr)
IE (1)	IE920453A1 (fr)
IL (1)	IL100928A (fr)
IT (1)	IT1244728B (fr)
MX (1)	MX9200600A (fr)
NO (1)	NO303713B1 (fr)
PH (1)	PH30130A (fr)
RU (1)	RU2136279C1 (fr)
SG (1)	SG59972A1 (fr)
UA (1)	UA27780C2 (fr)
WO (1)	WO1992014460A1 (fr)
ZA (1)	ZA921006B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69627137T2 (de) *	1995-06-07	2003-12-04	Ivax Research, Inc.	Verwendung von pentosan polysulfat zur behandlung von narben in chronischer fortschreitender gefässerkrankungen
RU2287327C2 (ru) *	2003-10-16	2006-11-20	Юрий Антонович Кошелев	Средство для лечения и профилактики атеросклероза
EP1868577A4 (fr) *	2005-04-15	2009-12-09	Reddys Lab Inc Dr	Particules de lacidipine
WO2007096694A1 (fr) *	2006-02-22	2007-08-30	Ramiro Vergara	Combinaison de principes actifs neuro-activateurs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS597163A (ja) *	1982-07-02	1984-01-14	Yamanouchi Pharmaceut Co Ltd	抗動脈硬化剤
NZ212895A (en) *	1984-08-22	1988-07-28	Glaxo Spa	1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) *	1984-12-10	1985-01-16	Fujisawa Pharmaceutical Co	Anti-arteriosclerotic composition

1991
- 1991-02-13 IT ITMI910359A patent/IT1244728B/it active IP Right Grant
1992
- 1992-02-08 AT AT92102146T patent/ATE157004T1/de not_active IP Right Cessation
- 1992-02-08 US US08/094,150 patent/US5455257A/en not_active Expired - Lifetime
- 1992-02-08 DK DK92102146.5T patent/DK0499920T3/da active
- 1992-02-08 RU RU93054780A patent/RU2136279C1/ru active
- 1992-02-08 ES ES92102146T patent/ES2106098T3/es not_active Expired - Lifetime
- 1992-02-08 JP JP4503957A patent/JP2996725B2/ja not_active Expired - Fee Related
- 1992-02-08 EP EP92903946A patent/EP0576433A1/fr not_active Withdrawn
- 1992-02-08 EP EP92102146A patent/EP0499920B1/fr not_active Expired - Lifetime
- 1992-02-08 CZ CS931650A patent/CZ281760B6/cs not_active IP Right Cessation
- 1992-02-08 CA CA002103805A patent/CA2103805C/fr not_active Expired - Fee Related
- 1992-02-08 UA UA93004263A patent/UA27780C2/uk unknown
- 1992-02-08 SG SG1996007490A patent/SG59972A1/en unknown
- 1992-02-08 AU AU12231/92A patent/AU646929B2/en not_active Ceased
- 1992-02-08 DE DE69221649T patent/DE69221649T2/de not_active Expired - Fee Related
- 1992-02-08 WO PCT/EP1992/000276 patent/WO1992014460A1/fr not_active Ceased
- 1992-02-12 IE IE045392A patent/IE920453A1/en not_active IP Right Cessation
- 1992-02-12 ZA ZA921006A patent/ZA921006B/xx unknown
- 1992-02-12 PH PH43915A patent/PH30130A/en unknown
- 1992-02-12 IL IL10092892A patent/IL100928A/xx not_active IP Right Cessation
- 1992-02-12 MX MX9200600A patent/MX9200600A/es unknown
1993
- 1993-08-12 KR KR1019930702402A patent/KR100188171B1/ko not_active Expired - Fee Related
- 1993-08-12 NO NO932874A patent/NO303713B1/no not_active IP Right Cessation
1997
- 1997-09-09 GR GR970402303T patent/GR3024661T3/el unknown

Also Published As

Publication number	Publication date
UA27780C2 (uk)	2000-10-16
EP0576433A1 (fr)	1994-01-05
CA2103805A1 (fr)	1992-08-14
CZ281760B6 (cs)	1997-01-15
WO1992014460A1 (fr)	1992-09-03
CZ165093A3 (en)	1994-03-16
DE69221649D1 (de)	1997-09-25
NO932874D0 (no)	1993-08-12
MX9200600A (es)	1992-10-30
AU1223192A (en)	1992-09-15
JP2996725B2 (ja)	2000-01-11
IT1244728B (it)	1994-08-08
SG59972A1 (en)	1999-02-22
DE69221649T2 (de)	1997-12-11
JPH06505002A (ja)	1994-06-09
ITMI910359A1 (it)	1992-08-13
EP0499920A1 (fr)	1992-08-26
ES2106098T3 (es)	1997-11-01
NO303713B1 (no)	1998-08-24
IL100928A (en)	1997-02-18
EP0499920B1 (fr)	1997-08-20
NO932874L (no)	1993-08-12
ZA921006B (en)	1992-12-30
RU2136279C1 (ru)	1999-09-10
ITMI910359A0 (it)	1991-02-13
GR3024661T3 (en)	1997-12-31
CA2103805C (fr)	2002-09-17
HK1009585A1 (en)	1999-06-04
DK0499920T3 (da)	1998-01-26
US5455257A (en)	1995-10-03
AU646929B2 (en)	1994-03-10
ATE157004T1 (de)	1997-09-15
KR100188171B1 (en)	1999-06-01
IE920453A1 (en)	1992-08-12

Similar Documents

Publication	Publication Date	Title
NZ305166A (en)	1998-12-23	5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments
DE69324036D1 (de)	1999-04-22	Dentales implantat
BG60677B1 (en)	1995-12-29	Fungicide oxazolidinones
ATE121295T1 (de)	1995-05-15	Augentropfenarzneimittel.
DE68927160D1 (de)	1996-10-17	Verwendung von N-Butyl-Deoxynojirimycin zur Behandlung von Herpes
DE69300062D1 (de)	1995-03-23	Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
HUP9900927A3 (en)	2002-02-28	Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
KR100188171B1 (en)	1999-06-01	Use of lacidipine for the treatment of arteriosclerosis
LV12251A (lv)	1999-04-20	2-fenil-1,2-benzizoseleazol-3(2h)-ona pielietojums medikamenta razosanai kas paredzets alcheimera slimibas profilaksei un/vai terapijai
EE04235B1 (et)	2004-02-16	Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks
DE59310153D1 (de)	2001-04-12	Verfahren zur Herstellung von 4-Hydroxy-2.2.6.6-tetramethylpiperidin
RU93054780A (ru)	1996-10-10	Применение лацидипина для лечения артериосклероза
DE69231883D1 (de)	2001-07-26	4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
ITRM910211A0 (it)	1991-03-29	Impianto dentale endosseo.
FR2695822B1 (fr)	1995-06-16	Implant dentaire evolue et evolutif.
DE69215106D1 (de)	1996-12-12	Zahnimplantat
ATE122352T1 (de)	1995-05-15	3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
NO924767L (no)	1994-06-13	Anordning for bedring av miljö i munnhulen ved tannbehandling
EP0800393A4 (fr)	1998-05-06	Monomeres de 4,4-(disubstitue)cyclohexan-1-one et composes correspondants
ES1023915Y (es)	1994-04-01	Implante dental.
ATE144894T1 (de)	1996-11-15	Zahnimplantat
BR7201445U (pt)	1993-10-05	Implante dental
DE69616484D1 (de)	2001-12-06	Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel